Exploring the State of the Science of Stem Cell Transplantation and Posttransplant Disability Proceedings of a Workshop (2022) / Chapter Skim
Currently Skimming:
Appendix C: Biographical Sketches of Workshop Planning Committee Members and Speakers
Appendix C: Biographical Sketches of Workshop Planning Committee Members and Speakers
Pages 81-92
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 81... ...
A graduate of Wesleyan University and Boston University Law School, Professor Rosenbaum has devoted her career to issues of health justice for populations who are medically underserved as a result of race, poverty, disability, or cultural exclusion. An honored teacher and scholar, a highly popular speaker, and a widely read writer on many aspects of health law and policy, Professor Rosenbaum has emphasized public engagement as a core element of her professional life, providing public service to 6 presidential administrations and 19 Congresses.
|
From page 82... ...
Notably, he helped develop Fred Hutch's renowned program in blood stem cell transplantation. He also participated in Fred Hutch's pioneering work to develop targeted antibody-based cancer therapies.
|
From page 83... ...
She is a member of the Oncology Nursing Society and the American Psychosocial Oncology Society and served as a cochair for the NIH Hematopoietic Stem Cell Transplant (HSCT) Late Effects Initiative PatientCentered Outcomes Working Group.
|
From page 84... ...
As a translational research scientist, she investigates hematopoiesis, stem cell biology, leukemogenesis, natural killer cell biology, and gene therapies targeting hematopoietic stem cells using nonhuman primate models predictive of human biology. She has carried out landmark clinical trials in gene therapies, transplantation, autoimmune disease, and bone marrow failure, including recent studies leading to the regulatory approval of the thrombopoietin mimetic eltrombopag as a new treatment for bone marrow failure.
|
From page 85... ...
She has served on numerous NIH advisory panels, coauthored more than 400 publications addressing diverse issues in HSCT bone marrow transplantation, and been continuously funded by the NIH since 1990. Leslie S
|
From page 86... ...
Her clinical interests include hemoglobinopathies (thalassemia and sickle cell disease) , bone marrow failure syndromes, and stem cell transplantation in pediatric patients.
|
From page 87... ...
Steven Devine, M.D., is Chief Medical Officer at the National Marrow Donor Program (NMDP) /Be The Match and associate scientific director at the Center for International Blood and Marrow Transplant Research (CIBMTR)
|
From page 88... ...
She serves as cochair of the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research. She recently chaired the Late Effects, Quality of Life, and Economics Committee for the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
|
From page 89... ...
Miguel-Angel Perales, M.D., is the chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center in New York, as well as an associate professor of medicine at Weill Cornell Medical College. He is an internationally recognized leader in the field of hematopoietic stem cell transplantation and cellular therapy and serves as chair of the Alliance for Clinical Trials in Oncology Transplantation and Cell-Based Therapies Committee, vice-chair of the Board of Directors of Be the Match (National Marrow Donor Program)
|
From page 90... ...
He is the immediate past chair and current member of the Board of Directors of the National Marrow Donor Program and serves on a number of cell therapy advisory boards, monitoring boards, and steering committees for several organizations including the Foundation for the Accreditation of Cell Therapy, the Association of American Cancer Institutes, the Society for Immunotherapy of Cancer, and the Center for International Blood and Marrow Transplant Research. He is the recipient of several prestigious awards from local and national organizations that include recognition for service, professionalism, and mentorship.
|
From page 91... ...
Among other national responsibilities, she has served on invited national panels to develop cancer-related guidelines, including for hematopoietic cell transplantation (HCT) and general cancer survivorship, pain, anxiety/depression, and other symptom management.
|
From page 92... ...
He has served on the National Institute of Diabetes and Digestive and Kidney Diseases/National Institute of Arthritis and Musculoskeletal and Skin Diseases Institutional Review Board for more than 15 years, is a founding member of the NIH Bone Marrow Transplant Consortium, and is an active member of the NIH Intramural Gene Therapy Task Force.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.